← All stocks

Estrella Immunopharma, Inc.

ESLA Net buying

CIK 0001844417 #4891 in the set updated 17 Sep 2026

Bought (12 mo)

$2.49K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$2.49K

+$2.49K against sales at will

By person

2 insiders · 4 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Xu Jiandong

Chief Financial Officer

$2.49K (2)

—

+$2.49K

382,188

0.8786%

$508.31K

+36.5%

Liu Cheng

CEO

—

397,437

0.9137%

$528.59K

+33.6%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 3

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 200,000

History held since 17 Mar 2022